SUMMARY -Permanent immunosuppression is necessary to prevent rejection after kidney transplantation. However, it may predispose patients to diff erent conditions and diseases including oral lesions. Th e most common benign oral lesions in kidney transplant recipients are gingival hyperplasia, oral candidiasis, hairy leukoplakia and saburral tongue. Oral form of Kaposi sarcoma, although rarely, can also be seen in kidney transplant patients. In this review, we present the incidence, etiology, clinical fi ndings, diagnosis and treatment options for these lesions. For kidney transplant recipients, it is important to maintain good oral hygiene and care, as well as regular professional control by the dentist. Th is approach can reduce the number and severity of oral lesions.
Introduction
Kidney transplantation (KT) is the treatment of choice for patients with end-stage renal disease. It is the most cost-eff ective and improving quality of life strategy. In the last 20 years, the number of KT has increased, with more than 13 000 cases in the United States of America (USA) 1 and more than 200 cases in Croatia per year (208 KT in 2013) 1 . Due to improvement in patient selection, kidney preservation, immunosuppression, surgical techniques, diagnosis and treatment of complications, as well as in follow up, survival of grafts and KT patients has been signifi cantly improved. In the USA, one-year kidney graft survival is 80%-85% for cadaveric and more than 90% for living donor transplants 2 . Kidney allograft recipients usually have signifi cant comorbidities, have been exposed to dialysis for longer period of time, and demand permanent immunosuppression. Th erefore, they are liable to diff erent diseases including oral lesions. In this review, we present the most common benign oral diseases in KT recipients and oral form of Kaposi sarcoma.
Gingival Hyperplasia
Gingival hyperplasia (GH) or gingival overgrowth is a well known side eff ect of cyclosporine, calcium channel blockers such as nifedipine and anticonvulsants 3, 4 . Th e reported incidence of drug induced GH varies from 8% to 85%, depending on the study population and methodology 3, 5 . Although the mechanism of drug-induced GH remains unknown and probably is multifactorial, recent studies show that cyclosporine promotes GH, aff ecting diff erent signaling molecules in gingival fi broblasts 6 . Calcium channel blockers change calcium ion fl ux which may infl uence collagenase, resulting in changes in collagen production and breakdown in gingival fi broblast, leading to collagen deposition in gingival tissue 7, 8 . In humans, there is no proven connection between GH and patient sex, diagnosis before transplantation, dialysis, age at transplantation or time after transplantation, but it has been shown that cyclosporine dose and plasma level were signifi cant risk factors for development and extent of GH. Also, gingival infl ammation and tooth plaque were strongly associated with GH 9 . Children and adolescents are more prone to this disease than adults 10 , and it is important to note that the patients developing severe GH had evidence of GH prior to kidney transplantation 11 . Gingival hyperplasia or gum status can be scored in three or, better, four grades: grade 0 (normal gum); grade 1 or mild GH (slight overgrowth and thickening of marginal gum, covering up to 1/3 of the crown); grade 2 or moderate GH (moderate gum overgrowth covering ½ of the crown), which is the most common form; and grade 3 or severe GH (severe gum overgrowth covering 2/3 of the crown, or aff ecting all of adhered gum) 12 . Th e most aff ected are usually labial aspects of both superior and inferior anterior teeth 13 . At the beginning of disease, interdental papillae become soft, red nodules which can easily bleed. Progressive hyperplasia extends to labial, buccal, palatal and lingual gingiva, later due to fi brotic changes the tissue appears pink, fi rm and resilient to palpation. In most severe cases, almost whole crown can be covered with gum tissue. GH can be painful; it can cause diffi culties on eating and speaking, as well as aesthetic problems.
Although withdrawal of therapy would be the best option, it is usually not possible in KT recipient. However, switching from cyclosporine to the newer immunosuppressive drug tacrolimus can lead to regression or complete resolution of GH 14 . Also, in patients having used tacrolimus from the beginning GH was present only sporadically 15 . Complete resolution of GH has been shown in adult KT recipients that have been treated with metronidazole 16 , but these results were not confi rmed in pediatric population 17 . Th e treatment with azithromycin also showed signifi cant improvement of GH in KT recipients 18 . Th e exact mechanisms how these drugs eff ect GH is not known, but they are probably related to their antimicrobial eff ect. Hyperplastic tissue can also be surgically removed, either by traditional gingivectomy or using laser as a newer, less invasive procedure 19 . Good oral hygiene and oral chlorhexidine rinse can be helpful for GH, mainly due to reduction in gingival infl ammation and plaque removal 20 .
Oral Candidiasis
Candida albicans may be present in normal oral fl ora in up to 50% of the population. It is the most common cause of oral candidiasis (70%-80%), although other Candida species such as Candida glabrata and Candida tropicalis can cause this disease as well 21 . Diseases or conditions like immunosuppression, which aff ect the host immune system, predispose patients to candida infections. Furthermore, immunosuppression is the most important factor for development and progression of oral candidiasis. In KT patients, Candida dubliniensis and Candida famata cause a signifi cant number of cases 7, 22 . Th e reported incidence of oral candidiasis in KT recipients varies from 4% to 43% [23] [24] [25] . Most commonly infected are the palate, tongue and buccal mucosa, although any oral mucosal surface can be involved. Th ere are diff erent clinical presentations of the disease, with erythematous, pseudomembranous and hyperplastic candidiasis being the most common types 26 . Erythematous candidiasis can be categorized into acute and chronic atrophic, angular cheilitis, median rhomboid glossitis and chronic multifocal candidiasis. Erythematous candidiasis is presented with erythema of the involved tissue, although atrophic changes and fi ssures can be seen as well. Pseudomembranous candidiasis is characterized with white-yellow plaques that can be wiped off revealing underlying mucosa with erythematous appearance which may bleed slightly. Th is form of candidiasis is most common in immunocompromised patients. Hyperplastic candidiasis or candidal leukoplakia is presented as white lesions, most commonly on buccal mucosa, although occasionally focal areas of erythema can be seen 26 . Diagnosis is usually based on clinical presentation and patients are often empirically treated with antifungal medication. To confi rm the disease, laboratory testing of clinical specimens have to be done. Samples from suspected areas can be obtained for culture using Sabouraud's agar plate, for exfoliative cytology or biopsy. On microscopy, candida hyphae or blastospores can be seen. For prevention and treatment of the disease, regular oral hygiene is mandatory. Rinsing of oral cavity with 0.1% hypochlorite or chlorhexidine solution is advisable 27 . Antifungal drugs such as nystatin can be applied topically or systemic therapy with fl uconazole or itraconazole can also be used.
Saburral Tongue
Saburral tongue is clinically presented as a yellowish-white superfi cial layer on the back of the tongue, resembling pseudomembranous candidiasis, but cannot be scraped off . Filiform papillae enlargement can also be seen. In the study by de la Rosa Garcia et al., suburral tongue was found in 22% of patients with KT 28 . Th e etiology of this condition is unknown, although some authors report on the association between suburral tongue and poor oral hygiene 29 . Furthermore, the accumulation of anaerobic bacteria in the subgingival plaque has been shown, suggesting that they may be important for this condition.
Hairy Leukoplakia
Leukoplakia is defi ned as a white adherent patch or plaque that can occur on oral mucosa. Oral hairy leukoplakia is a form of leukoplakia which presents as a white, hairy appearing lesion on one or both lateral borders of the tongue, which cannot be scraped off . It may also extend to buccal, labial or palatal mucosa. Th is condition is related to immune status and most patients are immunocompromised 30 . Hairy leukoplakia can be seen in 8%-11% of patients with KT 7, 31 . Histologically, severe hyperkeratosis and acanthosis with virally infected epithelial cells can be seen. Epstein-Barr virus was isolated from these cells and has been implicated as a causative factor for hairy leukoplakia 32 . Candida albicans can also be related to this lesion. Hairy leukoplakia is usually asymptomatic and has no malignant potential, therefore, no treatment is needed in most cases. However, antiviral medication such as acyclovir or gancyclovir, topical podophyllin or even surgical excision can be used, although recurrence is common as long as the cause of immunosuppression is present 32 .
Kaposi Sarcoma
Kidney transplant recipients have a signifi cantly higher frequency of malignant lesions as compared with general population and the risk is increasing with each year after transplantation. Kaposi sarcoma accounts for 5.7%-11% of all neoplasms arising after KT 33, 34 . It is an angiogenic tumor the development of which can be divided into three phases, i.e. the patch or macular stage, the plaque, and the nodular stage 35 . Histopathologically, the disease is characterized by endothelium-lined vascular spaces and spindle-shaped cells 36 . Kaposi sarcoma can be seen as oral lesion (palate and gingiva) after renal transplantation, and it is important to know that in oral presentation, Kaposi sarcoma may mimic gingival hyperplasia. Th e etiology of the disease is unknown, although Kaposi sarcoma has been strongly related to immunosuppression and human herpes virus 8 37 . Th e disease is usually asymptomatic, although the lesion itself can be seen in the mouth. In KT patients with Kaposi sarcoma, immunosuppression with cyclosporine and mycophenolate mofetil should be replaced with an mTOR inhibitor (sirolimus or everolimus), and the disease can be treated with surgery, irradiation and chemotherapy (paclitaxel) 38 .
Discussion and Conclusion
Approximately two-thirds of KT patients have at least one oral mucosa lesion 28 . Th e most common oral mucosa lesions that can be found after thorough oral examination of renal transplant recipients are gingival hyperplasia, oral candidiasis, hairy leukoplakia and saburral tongue 39 . All these lesions can be related to immunosuppressive drugs, either as their side eff ect or as a direct consequence of the patient immune status. Th e most common drugs used for immunosuppression after KT are calcineurin inhibitors (cyclosporine and tacrolimus), steroids, mycophenolate mofetil and mTOR inhibitors (mammalian target of rapamycin).
For KT patients, good oral hygiene and care, regular professional control by the dentist, as well as optimal treatment for diff erent oral lesions including change of immunosuppressive therapy when necessary, can reduce the number and severity of oral lesions.
Oral health is not only important for KT patients, but also for general population. It has recently been shown that diff erent chronic oral conditions such as periodontitis can be related to diff erent systemic diseases, e.g., anemia of chronic disease 40 . Posttransplant anemia is a chronic condition related to erythropoietin substitution and blood transfusion. Investigation of oral status in KT patients with anemia may give additional data on the possible link between oral diseases and chronic diseases such as anemia 41 .
